Analysis of Secondary Leukemia and Myelodysplastic Syndrome After Chemotherapy for Solid Organ Tumors Using the Food and Drug Administration Adverse Event Reporting System (FAERS)
Purpose: As the prognosis of cancer patients deteriorates, secondary carcinogenesis after chemotherapy, especially secondary hematological malignancies, becomes a serious problem. However, information on the frequency and time of onset of secondary hematological malignancies and the risk of hematolo...
Saved in:
Main Authors: | Takehiro Kawashiri (Author), Daisuke Kobayashi (Author), Mayako Uchida (Author), Shiori Hiromoto (Author), Masashi Inoue (Author), Hajime Ikeda (Author), Mizuki Inoue (Author), Takao Shimazoe (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dimethyl fumarate ameliorates chemotherapy agent-induced neurotoxicity in vitro
by: Takehiro Kawashiri, et al.
Published: (2018) -
Ameliorating effects of cystine and theanine in a cancer cachexia mouse model
by: Hibiki Kudamatsu, et al.
Published: (2023) -
Donepezil ameliorates oxaliplatin-induced peripheral neuropathy via a neuroprotective effect
by: Takehiro Kawashiri, et al.
Published: (2019) -
Difficulties in the differential diagnosis of myelodysplastic syndrome and acute leukemia
by: Alina V. Maltseva, et al.
Published: (2023) -
Pharmacovigilance Evaluation of Bendamustine-related Skin Disorders using the Japanese Adverse Drug Event Report Database
by: Mayako Uchida, et al.
Published: (2021)